Role of metformin in the diagnosis, prevention, and treatment of hepatocellular carcinoma
- PMID: 35545330
- PMCID: PMC10930065
- DOI: 10.11817/j.issn.1672-7347.2022.210118
Role of metformin in the diagnosis, prevention, and treatment of hepatocellular carcinoma
Abstract
Hepatocellular carcinoma is one of the most common malignant tumors in the world. Although there are many options for the treatment of hepatocellular carcinoma, such as surgical resection, interventional therapy, radiotherapy, chemotherapy, targeted therapy and liver transplantation, the poor therapeutic effect seriously reduces the quality of life for patients and also increases the social and economic burden. Metformin is originally used as the first-line drug for type 2 diabetes, but it has been found to play a certain effect in the prevention and treatment of malignant tumor. The potential roles of metformin against hepatocellular carcinoma, such as regulation of the microenvironment, proliferation signal pathway, metabolism, invasion and metastasis, apoptosis, autophagy, and epigenetics of hepatoma cells. It provides a new choice for the prevention and treatment of hepatocellular carcinoma.
肝细胞癌是全球最常见的恶性肿瘤之一,虽然对肝细胞癌的治疗有手术切除、介入治疗、放射治疗、化学治疗、靶向治疗以及肝移植等多种方案,但总体效果并不理想。这严重影响患者的生活质量,也加重了社会和经济负担。二甲双胍原为2型糖尿病的一线用药,但人们发现其在恶性肿瘤防治中也具有一定的作用。二甲双胍在肝细胞癌防治中具有潜在作用,如调控肝细胞癌微环境、增殖信号通路、代谢、侵袭和转移、凋亡、自噬和表观遗传学等,为肝细胞癌的防治提供了新选择。.
Keywords: hepatocellular carcinoma; mechanism of action; metformin.
Conflict of interest statement
作者声称无任何利益冲突。
Similar articles
-
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies.Gut. 2013 Apr;62(4):606-15. doi: 10.1136/gutjnl-2011-301708. Epub 2012 Jul 7. Gut. 2013. PMID: 22773548
-
Recent Insights of Metformin on Hepatocellular Carcinoma (HCC).Mini Rev Med Chem. 2023;23(11):1154-1166. doi: 10.2174/1389557522666220623150717. Mini Rev Med Chem. 2023. PMID: 35747976 Review.
-
Diabetes mellitus and metformin in hepatocellular carcinoma.World J Gastroenterol. 2016 Jul 21;22(27):6100-13. doi: 10.3748/wjg.v22.i27.6100. World J Gastroenterol. 2016. PMID: 27468203 Free PMC article. Review.
-
Metformin and risk of hepatocellular carcinoma: are statins the missing link?Gut. 2013 Jun;62(6):951-2. doi: 10.1136/gutjnl-2012-304232. Epub 2012 Dec 22. Gut. 2013. PMID: 23263525 No abstract available.
-
Authors' response: Metformin and risk of hepatocellular carcinoma--a study focused on anti-diabetic agents.Gut. 2013 Jun;62(6):952. doi: 10.1136/gutjnl-2012-304319. Epub 2013 Jan 26. Gut. 2013. PMID: 23355550 No abstract available.
Cited by
-
Preliminary Study on Pharmacokinetics and Antitumor Pharmacodynamics of Folic Acid Modified Crebanine Polyethyleneglycol-Polylactic Acid Hydroxyacetic Acid Copolymer Nanoparticles.Int J Nanomedicine. 2024 Oct 17;19:10513-10536. doi: 10.2147/IJN.S477027. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39435040 Free PMC article.
References
-
- 孔顺, 杨志叶, 强云沐. 二甲双胍治疗原发性肝癌的研究进展[J]. 临床与病理杂志, 2019, 39(3): 652-656. 10.3978/j.issn.2095-6959.2019.03.032. - DOI
- KONG Shun, YANG Zhiye, QIANG Yunmu. Advances in the treatment of primary hepatocellular carcinoma treatment with metformin[J]. International Journal of Pathology and Clinical Medicine, 2019, 39(3): 652-656. 10.3978/j.issn.2095-6959.2019.03.032. - DOI
-
- 刘磊, 费锐, 仝巧云, 等. 乙型肝炎病毒表面抗原调控Fas介导的肝癌细胞株凋亡[J]. 华中科技大学学报(医学版), 2018, 47(4): 388-393. 10.3870/j.issn.1672-0741.2018.04.002. - DOI
- LIU Lei, FEI Rui, TONG Qiaoyun, et al. . Regulation of fas-mediated apoptosis of hepatoma cells by hepatitis B virus surface antigen[J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2018, 47(4): 388-393. 10.3870/j.issn.1672-0741.2018.04.002. - DOI
-
- 杨智, 仝巧云, 刘伟. 乙型肝炎病毒e抗原抑制Fas介导的肝细胞凋亡[J]. 华中科技大学学报(医学版), 2019, 48(2): 143-148. 10.3870/j.issn.1672-0741.2019.02.003. - DOI
- YANG Zhi, TONG Qiaoyun, LIU Wei. Hepatitis B virus e antigen inhibits apoptosis of hepatoma cells mediated by fas[J]. Acta Medicinae Universitatis Scientiae et Technologiae Huazhong, 2019, 48(2): 143-148. 10.3870/j.issn.1672-0741.2019.02.003. - DOI
-
- 费锐, 刘磊. 阿司匹林抗肝癌的作用机制及临床研究进展[J]. 临床与病理杂志, 2020, 40(6): 1572-1578. 10.3978/j.issn.2095-6959.2020.06.040. - DOI - PubMed
- FEI Rui, LIU Lei. Mechanism and clinical research progress of aspirin against liver cancer[J]. Journal of Clinical and Pathological Research, 2020, 40(6): 1572-1578. 10.3978/j.issn.2095-6959.2020.06.040. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical